TrialAddiction science & clinical practice2022

Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates.

Dale Terasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.